Silence Therapeutics (SLN) Asset Utilization Ratio: 2021-2025
Historic Asset Utilization Ratio for Silence Therapeutics (SLN) over the last 3 years, with Sep 2025 value amounting to 0.17.
- Silence Therapeutics' Asset Utilization Ratio rose 6.41% to 0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year increase of 6.41%. This contributed to the annual value of 0.27 for FY2024, which is 37.71% down from last year.
- Latest data reveals that Silence Therapeutics reported Asset Utilization Ratio of 0.17 as of Q3 2025, which was up 6.80% from 0.16 recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Asset Utilization Ratio ranged from a high of 255.42 in Q4 2021 and a low of 0.14 during Q1 2025.
- Moreover, its 3-year median value for Asset Utilization Ratio was 0.24 (2024), whereas its average is 0.54.
- In the last 5 years, Silence Therapeutics' Asset Utilization Ratio slumped by 91.24% in 2024 and then climbed by 6.41% in 2025.
- Quarterly analysis of 5 years shows Silence Therapeutics' Asset Utilization Ratio stood at 255.42 in 2021, then reached 2.42 in 2022, then crashed by 57.20% to 0.38 in 2023, then declined by 29.35% to 0.27 in 2024, then grew by 6.41% to 0.17 in 2025.
- Its Asset Utilization Ratio was 0.17 in Q3 2025, compared to 0.16 in Q2 2025 and 0.14 in Q1 2025.